Ulcerative colitis, a chronic inflammatory bowel disease, presents treatment challenges due to its variable symptoms and unpredictable flare-ups. The global market is set to grow, driven by biologic ...

A head-to-head comparison of the JAK inhibitor drug tofacitinib and chimeric monoclonal antibody infliximab in the treatment of acute severe ulcerative colitis (ASUC ... for multivariate factors ...

Stress can make ulcerative colitis feel worse. Lifestyle changes like exercising, sleeping better, and practicing yoga could help keep symptoms at bay.

A large cohort study finds a U-shaped association between caffeine intake and chronic constipation risk; intakes < 204 mg/d ...

TEVA stock jumps 21.6% in three months on branded drug growth, biosimilar launches, and margin-boosting cost cuts.

Growing evidence suggests that regular exposure to our pets’ microbes — particularly in early life — can help build a ...

LAVAL, QC / ACCESS Newswire / July 10, 2025 / Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), today announced that PrCABTREOTM (clindamycin phosphate, adapalene a ...

Fatty acids and other food compounds may change disease activity among individuals with inflammatory bowel diseases.

MIDDLETOWN, DE, USA I July 10, 2025 I Earendil Labs, an AI-empowered biotechnology company, announced that it has completed cohort 1 dosing in a phase 1 trial ...